Cell-SELEX-based selection of ssDNA aptamers for specifically targeting BRAF V600E-mutated melanoma-Reference-Cited by-同舟云学术

Cell-SELEX-based selection of ssDNA aptamers for specifically targeting BRAF V600E-mutated melanoma

Published:2022 Issue:1 Volume:147 Page:187-195
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Li Wanming¹,Bing Tao²^ORCID,Wang Rui³,Jin Sihan¹,Shangguan Dihua²^ORCID,Chen Hang⁴^ORCID

Affiliation:

1. Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang North New Area, Shenyang 110122, Liaoning, China

2. Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, CAS Research/Education Center for Excellence in Molecular Sciences, institute of chemistry, Chinese Academy of Sciences, 100190, Beijing, China

3. Department of Stem Cells and Regenerative Medicine, Key Laboratory of Cell Biology, Ministry of Public Health of China, and Key Laboratory of Medical Cell Biology, Ministry of Education of China, China Medical University, Shenyang North New Area, Shenyang 110122, Liaoning, China

4. Experiment Teaching Center of Functional Subjects, College of Basic Medicine, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China

Abstract

Malignant melanoma is regarded as the most aggressive form of skin cancer, and is responsible for most death caused by skin cancer.

Funder

Natural Science Foundation of Liaoning Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/AN/D1AN01579F

Reference37 articles.

1. Cancer statistics, 2020

2. Final Version of 2009 AJCC Melanoma Staging and Classification

3. Malignant Melanoma

4. Historical review of melanoma treatment and outcomes

5. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers as an approach to targeted cancer therapy;Cancer Cell International;2024-03-16

2. Development of a modularized aptamer targeting the nuclear T-cell suppressor PAC1;The Analyst;2023

3. Aptamer-functionalized micelles for targeted cancer therapy;Aptamers Engineered Nanocarriers for Cancer Therapy;2023

4. Identification of the target protein of the metastatic colorectal cancer-specific aptamer W3 as a biomarker by aptamer-based target cells sorting and functional characterization;Biosensors and Bioelectronics;2022-10

5. Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX;Scientific Reports;2022-09-28